By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said today that it has signed a deal to buy Lomb Scientific, a provider of lab chemicals, consumables, and instruments in Australia and New Zealand, for an undisclosed sum.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.
Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.
The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.
Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.